+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Schizophrenia"

Mental Wellness Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Mental Wellness Market - Global Outlook & Forecast 2022-2027

  • Report
  • April 2022
  • 240 Pages
  • Global
From
From
Mental Health Application: Technologies and Global Markets - Product Thumbnail Image

Mental Health Application: Technologies and Global Markets

  • Report
  • September 2023
  • 115 Pages
  • Global
From
The Future of Mental Health Management - Product Thumbnail Image

The Future of Mental Health Management

  • Report
  • June 2023
  • 71 Pages
  • Global
From
From
Anorexia Nervosa - Pipeline Insight, 2024 - Product Thumbnail Image

Anorexia Nervosa - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 60 Pages
  • Global
From
From
Behavioural Health Market Report and Forecast 2023-2031 - Product Thumbnail Image

Behavioural Health Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Mental Health Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Mental Health Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
From
United Arab Emirates Mental Health Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Mental Health Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • October 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
Loading Indicator

Schizophrenia is a mental disorder characterized by abnormal social behavior and a distorted perception of reality. It is one of the most disabling and emotionally devastating mental illnesses, affecting approximately 1% of the population worldwide. Symptoms of schizophrenia can include hallucinations, delusions, disorganized speech and behavior, and cognitive deficits. The schizophrenia market within the context of mental health is a rapidly growing sector, driven by the increasing prevalence of the disorder and the need for better treatments. The market is expected to benefit from the development of novel drugs and therapies, as well as the increasing awareness of mental health issues. Additionally, the increasing focus on personalized medicine and the development of digital health technologies are expected to drive the market growth. Some of the key players in the schizophrenia market include Eli Lilly, Johnson & Johnson, Novartis, Pfizer, Otsuka Pharmaceutical, Sunovion Pharmaceuticals, Allergan, and Merck. Show Less Read more